Cross-sectional study on attitudes among general practitioners towards pneumococcal vaccination for middle-aged and elderly population in Hong Kong.

Lancelot W H Mui, Alvin Y S Chan, Albert Lee, John Lee
Author Information
  1. Lancelot W H Mui: JC School of Public Health and Primary Care, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China.

Abstract

OBJECTIVE: To study the attitudes among general practitioners towards pneumococcal vaccination for middle-aged (50-64) and elderly population (over 65) in Hong Kong and the factors affecting their decision to advise pneumococcal vaccination for those age groups.
DESIGN: Cross-sectional study of general practitioners in private practice in Hong Kong.
PARTICIPANTS: Members of Hong Kong Medical Association delivering general practice services in private sector.
MEASURING TOOL: Self-administered questionnaire.
MAIN OUTCOME MEASURES: Intention to recommend pneumococcal vaccination, barriers against pneumococcal vaccination.
RESULTS: 53.4% of the respondents would actively recommend pneumococcal vaccination to elderly patients but only 18.8% would recommend for middle-aged patients. Consultation not related to pneumococcal vaccine was the main reason for not recommending pneumococcal vaccine (43.6%). Rarity of pneumonia in their daily practice was another reason with 68.4% of respondents attending five or less patients with pneumonia each year. In multivariate analysis, factors such as respondents would get vaccination when reaching age 50 (ORm 10.1), and attending 6 pneumonia cases or more per year (ORm 2.28) were found to be associated with increasing likelihood for recommending vaccination to the middle-aged. While concerns of marketing a product (ORm 0.41), consultation not related to vaccination (ORm 0.45) and limited time (ORm 0.38) were factors that reduced the likelihood.
CONCLUSION: Public policy is needed to increase the awareness of impact of pneumococcal pneumonia and the availability of preventive measures.

References

  1. CMAJ. 2008 Oct 7;179(8):773-7 [PMID: 18838452]
  2. BMC Public Health. 2012 Mar 22;12:222 [PMID: 22436146]
  3. Aust Fam Physician. 2009 Nov;38(11):891-5 [PMID: 19893837]
  4. Arch Intern Med. 2001 Dec 10-24;161(22):2702-8 [PMID: 11732935]
  5. Vaccine. 2003 Mar 28;21(13-14):1510-7 [PMID: 12615448]
  6. Int J Gen Med. 2012;5:967-74 [PMID: 23204861]
  7. Vaccine. 2009 Mar 4;27(10):1504-10 [PMID: 19171174]
  8. Vaccine. 2008 Oct 16;26(44):5633-40 [PMID: 18706955]
  9. J Urban Health. 2007 May;84(3 Suppl):i75-85 [PMID: 17356902]
  10. Health Educ Q. 1984 Spring;11(1):1-47 [PMID: 6392204]
  11. Health Promot Int. 2011 Jun;26(2):148-62 [PMID: 20739325]
  12. Soc Sci Med. 2009 Aug;69(3):475-80 [PMID: 19540642]
  13. Hong Kong Med J. 2010 Apr;16(2):106-15 [PMID: 20354244]
  14. Commun Dis Intell. 2000 Apr;24(4):89-92 [PMID: 10851795]
  15. Prev Med. 2005 May;40(5):595-601 [PMID: 15749144]
  16. Med J Aust. 2004 Apr 19;180(8):409-10 [PMID: 15089732]
  17. J Adolesc Health. 2008 Oct;43(4 Suppl):S61-7 [PMID: 18809147]
  18. Aust Fam Physician. 2009 Aug;38(8):605-8 [PMID: 19893783]
  19. J Epidemiol Community Health. 2010 Feb;64(2):101-2 [PMID: 20056961]
  20. Health Promot Int. 2012 Jun;27(2):261-74 [PMID: 21421579]
  21. Vaccine. 2001 Sep 14;19(32):4760-7 [PMID: 11535327]
  22. N Engl J Med. 1999 Nov 18;341(21):1612-6 [PMID: 10577119]
  23. Vaccine. 2004 Nov 25;23(2):132-8 [PMID: 15531029]
  24. Med J Aust. 2002 Feb 4;176(3):118-21 [PMID: 11936308]
  25. Vaccine. 2009 Jun 8;27(28):3775-9 [PMID: 19464561]
  26. Vaccine. 2005 Apr 15;23(21):2756-61 [PMID: 15780723]
  27. Lancet. 2008 Nov 8;372(9650):1661-9 [PMID: 18994664]
  28. Clin Infect Dis. 2007 Jun 15;44(12):e104-8 [PMID: 17516388]

MeSH Term

Adult
Age Factors
Aged
Cross-Sectional Studies
Female
General Practitioners
Health Knowledge, Attitudes, Practice
Health Services Needs and Demand
Hong Kong
Humans
Male
Middle Aged
Pneumococcal Vaccines
Pneumonia, Pneumococcal
Surveys and Questionnaires
Vaccination

Chemicals

Pneumococcal Vaccines

Word Cloud

Created with Highcharts 10.0.0pneumococcalvaccinationORmgeneralmiddle-agedHongKongpneumoniastudypractitionerselderlyfactorspracticerecommendrespondentspatients0attitudesamongtowardspopulationageCross-sectionalprivate4%relatedvaccinereasonrecommendingattendingyearlikelihoodOBJECTIVE:50-6465affectingdecisionadvisegroupsDESIGN:PARTICIPANTS:MembersMedicalAssociationdeliveringservicessectorMEASURINGTOOL:Self-administeredquestionnaireMAINOUTCOMEMEASURES:IntentionbarriersRESULTS:53actively188%Consultationmain436%Raritydailyanother68fivelessmultivariateanalysisgetreaching501016casesper228foundassociatedincreasingconcernsmarketingproduct41consultation45limitedtime38reducedCONCLUSION:Publicpolicyneededincreaseawarenessimpactavailabilitypreventivemeasures

Similar Articles

Cited By